Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Center for Behavioral Health is a nationwide network of outpatient facilities specializing in the treatment of substance use disorders, with a primary focus on opioid addiction. The organization provides Medication-Assisted Treatment (MAT) using FDA-approved medications such as methadone, Suboxone (buprenorphine + naloxone), and Vivitrol (naltrexone). In addition to pharmacotherapy, they offer comprehensive counseling, drug testing, and referral services to support long-term recovery. Operating across multiple states in the U.S., the company aims to provide affordable and effective evidence-based treatment. In January 2022, the organization was acquired by Behavioral Health Group (BHG), the largest network of Joint Commission-accredited outpatient opioid treatment centers in the United States, further expanding its reach and clinical resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Behavioral Health.